在莱维体病神经病理学中GBA变异的作用
Ronald L Walton1, Shunsuke Koga1, Alexandra I Beasley1
1Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Acta neuropathologica
|March 13, 2024
概括
GBA基因中的遗传变异与帕金森病和勒维体痴呆症有关. 这项研究发现,GBA变异与莱维体病的特定神经病理特征有关,影响疾病呈现.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 神经病理学神经病理学
背景情况:
- 葡萄糖脑蛋白酶 (GBA) 基因变异是帕金森病 (PD) 和患有莱维体痴呆症 (DLB) 的确立危险因素.
- GBA变体与莱维体病 (LBD) 的神经病理基础之间的确切关系仍然不完全理解.
研究的目的:
- 调查常见和罕见的GBA变体之间的关联,以及在大量LBD病例中的综合性神经病理结局.
- 确定GBA变异状态是否影响特定的LBD亚型,莱维体 (LB) 负担,神经纤维状 (NFT) 阶段,粉样蛋白病理和其他关键神经病理标记.
主要方法:
- 对943名被诊断患有LBD的个体的GBA基因测序数据的分析.
- 检查 42 个已识别的 GBA 变体 (4 种常见, 38 种罕见) 和 15 种独特的神经病理特征之间的关联,包括 LB 数量,布拉克 NFT 阶段,泰尔粉样阶段和 TDP-43 病理.
- 基因负担分析,以评估GBA变异对神经病理结果的累积影响.
主要成果:
- 常见的GBA变体p.L483P与较低的Brak NFT阶段有关.
- 整体GBA基因负担分析显示,与临床DLB的可能性增加,较低的布拉克NFT阶段,较低的Thalamyloid阶段和减少的-ubiquitin (pS65-Ub) 水平有关.
- 在LBD病例中,GBA变异最常见,这些病例表现出过渡性/扩散性LBD与低布拉克NFT和Thalamyloid阶段,这表明特定的神经病理特征.
结论:
- 在LBD中GBA变异经常在具有显著的勒维体病理但最小的阿尔茨海默氏病病理的病例中观察到.
- 这些发现完善了我们对GBA变异如何对LBD多样化的临床和病理谱的理解.
- 这些结果对理解GBA在PD,PD痴呆症和DLB的风险和病变发生中的作用有影响.
相关概念视频
Parkinson's Disease: Overview
544
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
544
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Alzheimer's Disease: Overview
481
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
481
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K


